SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-260012
Filing Date
2023-10-20
Accepted
2023-10-20 17:18:58
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d894177ds3.htm S-3 277760
2 EX-4.6 d894177dex46.htm EX-4.6 372860
3 EX-5.1 d894177dex51.htm EX-5.1 17928
4 EX-23.1 d894177dex231.htm EX-23.1 1566
5 EX-FILING FEES d894177dexfilingfees.htm EX-FILING FEES 29539
6 GRAPHIC g894177g1019000514106.jpg GRAPHIC 2213
7 GRAPHIC g894177g39x41.jpg GRAPHIC 67477
  Complete submission text file 0001193125-23-260012.txt   797151
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275125 | Film No.: 231337781
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services